Avoid common mistakes on your manuscript.
Correction to: Journal of Neurology https://doi.org/10.1007/s00415-023-12113-2
In the original version of this article, affiliation details for author Mohamed Y. Abdelgaied were incorrectly given as
1Clinical Pharmacy Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo (GUC), Cairo, Egypt
3Clinical Pharmacology and Pharmacogenomics Research Group, Pharmacology and Toxicology Department, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt
5Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2E1, Canada
but should have been
1Clinical Pharmacy Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo (GUC), Cairo, Egypt
5Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2E1, Canada
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdelgaied, M.Y., Rashad, M.H., El‑Tayebi, H.M. et al. Correction to: The impact of metformin use on the outcomes of relapse‑remitting multiple sclerosis patients receiving interferon beta 1a: an exploratory prospective phase II open‑label randomized controlled trial. J Neurol 271, 2925 (2024). https://doi.org/10.1007/s00415-024-12249-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-024-12249-9